RAS/BRAF mutational status in familial non-medullary thyroid carcinomas: A retrospective study

Author：                            

Publisher： Spandidos Publications

E-ISSN： 1792-1082|10|3|1875-1881

ISSN： 1792-1074

Source： Oncology Letters, Vol.10, Iss.3, 2015-01, pp. : 1875-1881

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medullary and non-medullary thyroid cancer in a family

By Ardern-jones Audrey   Harvey Roderick J.   Wilson Philip   Sharma Anup K.   Murday Vicky   Harmer Clive   Houlston Richard S.  

Acta Oncologica, Vol. 43, Iss. 7, 2004-10 ,pp. : 680-681

Informa Healthcare

Access to resources Recommend Favorite

Multicentric occurrence of multiple papillary thyroid carcinomas –HUMARA and BRAF mutation analysis

By  

Cancer Medicine, Vol. 4, Iss. 8, 2015-08 ,pp. : 1272-1280

John Wiley & Sons Inc

Access to resources Recommend Favorite

The RET Mutation E768D Confers a Late-onset Familial Medullary Thyroid Carcinoma – Only Phenotype with Incomplete Penetrance: Implications for Screening and Management of Carrier Status

By Dabir Tabib   Hunter Steven   Russell Colin   McCall Damien   Morrison Patrick  

Familial Cancer, Vol. 5, Iss. 2, 2006-06 ,pp. : 201-204

Springer Publishing Company

Access to resources Recommend Favorite

Analysis of somatic mutations in braf, CDKN2A/p16 and PI3KCA in patients with medullary thyroid carcinoma

By                    

Molecular Medicine Reports, Vol. 13, Iss. 2, 2016-01 ,pp. : 1653-1660

Spandidos Publications

Access to resources Recommend Favorite

PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms

By                        

International Journal of Oncology, Vol. 44, Iss. 2, 2014-01 ,pp. : 548-556

Spandidos Publications

Access to resources Recommend Favorite